Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Up 100.9% in April

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) saw a large increase in short interest in the month of April. As of April 30th, there was short interest totaling 17,577 shares, an increase of 100.9% from the April 15th total of 8,749 shares. Based on an average daily volume of 220,825 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the shares of the company are short sold.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

Shares of SGIOY traded down $0.08 during mid-day trading on Monday, reaching $9.62. 244,119 shares of the stock traded hands, compared to its average volume of 115,673. The company has a market cap of $16.37 billion, a price-to-earnings ratio of 12.03, a price-to-earnings-growth ratio of 0.72 and a beta of 0.10. Shionogi & Co., Ltd. Unsponsored ADR has a 1 year low of $7.64 and a 1 year high of $12.00. The firm has a fifty day moving average price of $10.42 and a 200 day moving average price of $9.80. The company has a current ratio of 5.84, a quick ratio of 5.21 and a debt-to-equity ratio of 0.01.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its quarterly earnings data on Tuesday, May 12th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.03. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 14.09% and a net margin of 41.08%.The company had revenue of $881.71 million for the quarter, compared to the consensus estimate of $895.52 million. As a group, equities research analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.78 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have commented on SGIOY. Zacks Research downgraded Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong sell” rating in a research note on Thursday, April 16th. The Goldman Sachs Group upgraded Shionogi & Co., Ltd. Unsponsored ADR to a “hold” rating in a research report on Wednesday, April 8th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Reduce”.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.